Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine
This study has been completed.
Study NCT00207168 Information provided by Bristol-Myers Squibb
First Received on September 12, 2005. Last Updated on April 8, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers